Several studies have shown a decrease in BDNF levels both in the hippocampus and in CSF during AD pathogenesis, suggesting that decreased BDNF signaling may contribute to the progression of hippocampal dysfunction in AD. Here, BDNF is linked to Alzheimer disease.